HLS Therapeutics宣布新的信贷协议

2025-08-20 20:41

HLS Therapeutics (TSX:HLS:CA) announced on Wednesday that the company has entered into a new credit agreement with National Bank of Canada as administrative agent, which provides for committed credit facilities of up to C$107 million.
The Agreement consists of a C$79 million term credit facility, a C$14 million delayed draw facility and a C$14 million revolving credit facility. In addition, HLS can increase facilities further through an uncommitted C$40 million accordion facility (subject to lender agreement).
Interest on the agreement accrues at a rate per month equal to the sum of the Canadian Overnight Repo Rate Average plus a range of 2.25% to 3.50% depending on the leverage ratio of the company at the time, informed the company.
National Bank serves as administrative agent and lead arranger, with the Toronto-Dominion Bank, Royal Bank of Canada, and Innovation Federal Credit Union as syndicate members.
The agreement replaced HLS's credit facility with JPMorgan Chase Bank, N.A. which had a maturity date of August 11, 2026.
On closing, the proceeds from the new term facility were used to repay the company's existing credit agreement in full. The new Agreement has a maturity date of August 19, 2029.
Source: Press Release

More on HLS Therapeutics